02.05 07:00 | dpa-AFX: GNW-Adhoc: Biotalys Starts Field Trials for Second Biofungicide |
30.04 07:00 | dpa-AFX: GNW-Adhoc: Biotalys Appoints Laura J. Meyer to Board of Directors |
23.04 18:00 | dpa-AFX: GNW-Adhoc: Results of the Ordinary and Extraordinary Shareholders' Meeting |
29.03 18:00 | dpa-AFX: GNW-Adhoc: Results of the Special Shareholders' Meeting |
20.03 18:00 | dpa-AFX: GNW-Adhoc: Invitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting |
18.03 07:00 | dpa-AFX: GNW-Adhoc: Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG |
26.02 18:00 | dpa-AFX: GNW-Adhoc: Invitation to a Special Shareholders' Meeting |
22.02 07:00 | dpa-AFX: GNW-Adhoc: Biotalys Reports Full-Year 2023 Financial Results and Business Highlights |
08.02 07:00 | dpa-AFX: GNW-Adhoc: Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S. |
31.01 18:00 | dpa-AFX: GNW-Adhoc: Information on the total number of voting rights and shares |
22.01 18:00 | dpa-AFX: GNW-Adhoc: Biotalys Notice of Full Year 2023 Results and Business Highlights |
19.12 07:00 | dpa-AFX: GNW-Adhoc: Biotalys Announces Results of Independent Field Trials in the U.S. |
05.10 07:00 | dpa-AFX: GNW-Adhoc: Kevin Helash commences role as Chief Executive Officer of Biotalys |
02.10 07:00 | dpa-AFX: GNW-Adhoc: Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase |
26.09 07:00 | dpa-AFX: GNW-Adhoc: Biotalys announces participation at upcoming scientific, industry and investor events |
23.08 07:00 | dpa-AFX: GNW-Adhoc: Biotalys Reports Half-Year 2023 Financial Results and Business Highlights |
20.07 07:00 | dpa-AFX: GNW-Adhoc: Invitation to a Special Shareholders' Meeting |
05.07 18:00 | dpa-AFX: GNW-Adhoc: Publication of transparency notification |
12.06 18:00 | dpa-AFX: GNW-Adhoc: Biotalys announces closing of private placement |
07.06 07:00 | dpa-AFX: GNW-Adhoc: Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for ?7 million |
|